Norepinephrine releasing agent
Norepinephrine Releasing Agent[edit]

A norepinephrine releasing agent (NRA) is a type of drug that induces the release of norepinephrine (also known as noradrenaline) from the presynaptic neuron into the synaptic cleft, thereby increasing the concentration of norepinephrine in the synapse. This action enhances the activity of the sympathetic nervous system, leading to various physiological effects.
Mechanism of Action[edit]
Norepinephrine releasing agents primarily act by entering the presynaptic neuron and promoting the release of norepinephrine stored in synaptic vesicles. This process often involves the reversal of the norepinephrine transporter (NET), which normally functions to reuptake norepinephrine from the synaptic cleft back into the neuron. By reversing this transporter, NRAs increase the extracellular concentration of norepinephrine, thereby enhancing adrenergic signaling.
Pharmacological Effects[edit]
The increase in norepinephrine levels due to NRAs leads to stimulation of adrenergic receptors throughout the body. This can result in:
- Increased heart rate and blood pressure
- Bronchodilation
- Enhanced alertness and focus
- Reduced appetite
These effects make NRAs useful in the treatment of conditions such as hypotension, narcolepsy, and attention deficit hyperactivity disorder (ADHD).
Examples of Norepinephrine Releasing Agents[edit]
One of the most well-known norepinephrine releasing agents is ephedrine, a naturally occurring compound found in plants of the genus Ephedra. Ephedrine is used both as a medication and as a stimulant. It is commonly used to prevent low blood pressure during spinal anesthesia, as a bronchodilator in asthma, and as a weight loss aid.
Clinical Uses[edit]
Norepinephrine releasing agents are used in various clinical settings:
- Hypotension: NRAs can be used to treat low blood pressure, especially during surgical procedures.
- Asthma and COPD: Due to their bronchodilatory effects, NRAs like ephedrine are used in the management of asthma and chronic obstructive pulmonary disease (COPD).
- Weight Loss: Some NRAs are used as appetite suppressants in weight loss programs.
Side Effects[edit]
The use of norepinephrine releasing agents can lead to several side effects, including:
These side effects are primarily due to the excessive stimulation of the sympathetic nervous system.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian